Protalix Biotherapeutics, Inc. (PLX)
2.78
+0.08
(+2.96%)
USD |
NYAM |
Oct 09, 16:00
2.68
-0.10
(-3.60%)
After-Hours: 05:05
Protalix Biotherapeutics Total Return Level : 2.78 for Oct. 9, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.78 |
| October 08, 2026 | 2.70 |
| October 07, 2026 | 2.71 |
| October 06, 2026 | 2.73 |
| October 05, 2026 | 2.71 |
| October 02, 2026 | 2.71 |
| October 01, 2026 | 2.68 |
| September 30, 2026 | 2.76 |
| September 29, 2026 | 2.69 |
| September 28, 2026 | 2.69 |
| September 25, 2026 | 2.72 |
| September 24, 2026 | 2.75 |
| September 23, 2026 | 2.80 |
| September 22, 2026 | 2.84 |
| September 21, 2026 | 2.75 |
| September 18, 2026 | 2.69 |
| September 17, 2026 | 2.70 |
| September 16, 2026 | 2.68 |
| September 15, 2026 | 2.66 |
| September 14, 2026 | 2.77 |
| September 11, 2026 | 2.64 |
| September 10, 2026 | 2.73 |
| September 09, 2026 | 2.67 |
| September 08, 2026 | 2.65 |
| September 04, 2026 | 2.67 |
| Date | Value |
|---|---|
| September 03, 2026 | 2.62 |
| September 02, 2026 | 2.59 |
| September 01, 2026 | 2.59 |
| August 31, 2026 | 2.57 |
| August 28, 2026 | 2.54 |
| August 27, 2026 | 2.61 |
| August 26, 2026 | 2.48 |
| August 25, 2026 | 2.40 |
| August 24, 2026 | 2.41 |
| August 21, 2026 | 2.38 |
| August 20, 2026 | 2.38 |
| August 19, 2026 | 2.35 |
| August 18, 2026 | 2.34 |
| August 17, 2026 | 2.29 |
| August 14, 2026 | 2.22 |
| August 13, 2026 | 2.36 |
| August 12, 2026 | 2.62 |
| August 11, 2026 | 2.43 |
| August 10, 2026 | 2.48 |
| August 07, 2026 | 2.46 |
| August 06, 2026 | 2.44 |
| August 05, 2026 | 2.44 |
| August 04, 2026 | 2.37 |
| August 03, 2026 | 2.32 |
| July 31, 2026 | 2.37 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Altimmune, Inc. | 10.13 |
| Taysha Gene Therapies, Inc. | 4.49 |
| Humacyte, Inc. | 0.4053 |
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 621.24 |